Etomidate and Unpredicted Seizures During Electroconvulsive Therapy
Etomidate and Unpredicted Seizures During Electroconvulsive Therapy
复制标题
DOI：
10.1097/yct.0b013e318061665c
复制
发表时间：
2007-09
期刊：
影响因子：
--
通讯作者：
Benjamin T. Griffeth;Abhishek Mehra
中科院分区：
文献类型：
--
作者：
Benjamin T. Griffeth;Abhishek Mehra
大约半个世纪以来，电休克疗法一直是一种新颖的治疗方法，对严重的精神疾病有效。多年来，通过添加麻醉，治疗方法得到了改进。过去几十年来，不同的诱导剂已用于临床实践，包括丙泊酚、美索比妥和依托咪酯。先前的文献很少提及依托咪酯诱导后不久的癫痫发作，通常仅在麻醉文献中提及。我们描述了 2 例具有不同人口统计、诊断和治疗情况的病例，这些病例使用依托咪酯作为诱导剂发生癫痫发作。
Electroconvulsive therapy has been a novel treatment for about half a century, effective for severe psychiatric conditions. Over the years, the treatment has been refined with the addition of anesthesia. Different inducing agents have been used in clinical practice over the last few decades including propofol, methohexital, and etomidate. Previous literature rarely mentions seizures soon after induction with etomidate and typically only in anesthesia literature. We describe 2 cases with different demographics, diagnosis, and treatment that had seizures with the use of etomidate as an inducing agent.